Calculas23 May 2019 11:51
From their Annual Statement 9/5/19..............................they rose 16% yesterday...........................
Scancell Holdings plc, which is AIM quoted, lost 50% of its value, equating to a loss of value of over £180,000 for the VCT. Whilst progress in life sciences companies can most definitely be non-linear, it is disappointing that Scancell's share price does not reflect clear progress made during the year.